|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.527
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.286
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.232
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.220
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.165
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.159
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.157
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.129
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.121
|
Human Mouse |
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.118
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.116
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.112
|
Human |
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.105
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.104
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.104
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.103
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.100
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.093
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.082
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.081
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.077
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.075
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.075
|
|
|
|
medium chain fatty acid metabolic process
|
GO:0051791 |
1 |
0.074
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.073
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.073
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.072
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.072
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.071
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.071
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.071
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.070
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.069
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.069
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.067
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.066
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.066
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.065
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.064
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.064
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.062
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.062
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.060
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.060
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.058
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.058
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.058
|
Human Mouse |
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.056
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.054
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.053
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.052
|
Human |
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.051
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.051
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.051
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.049
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.049
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.048
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.048
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.047
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.046
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.046
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.044
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.044
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.044
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.044
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.043
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.043
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.042
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.042
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.040
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.040
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.039
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.038
|
Human |
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.038
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.038
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.037
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.035
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.035
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.035
|
Human |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.035
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.034
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.033
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.032
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.032
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.032
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.032
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.032
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.031
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.031
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.030
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.029
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.029
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.029
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.029
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.029
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.029
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.028
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.028
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.027
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.027
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.026
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.026
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.026
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.026
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.026
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.026
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.026
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.025
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.025
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.025
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.025
|
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.025
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.025
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.025
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.025
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.024
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.024
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.024
|
Human Mouse |
|
|
phagocytosis
|
GO:0006909 |
66 |
0.024
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.024
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.024
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.024
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.024
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.023
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.023
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.023
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.023
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.023
|
Human Mouse |
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.022
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.022
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.022
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
cellular response to testosterone stimulus
|
GO:0071394 |
1 |
0.021
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.021
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.021
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.021
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.021
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.021
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.021
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.020
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.020
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.020
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.020
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.020
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.020
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.020
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.020
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.020
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
toxin catabolic process
|
GO:0009407 |
1 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.019
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.019
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.019
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.019
|
Rat |
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.019
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.019
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.019
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.018
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.018
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
cellular response to food
|
GO:0071240 |
1 |
0.018
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.018
|
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.018
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.018
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.018
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.018
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.018
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.018
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
negative regulation of iron ion transport
|
GO:0034757 |
1 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.017
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
regulation of vitamin metabolic process
|
GO:0030656 |
3 |
0.016
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.016
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.016
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.016
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.016
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.016
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.016
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.016
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.016
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.016
|
Human Mouse |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.016
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.015
|
|
|
|
secondary metabolite catabolic process
|
GO:0090487 |
1 |
0.015
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.015
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.015
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.015
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.015
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.015
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.015
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.015
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
Rat |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.014
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.014
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.014
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.014
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.014
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.014
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.014
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.014
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
|
neurotransmitter catabolic process
|
GO:0042135 |
3 |
0.014
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.014
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.014
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.014
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.014
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.014
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.014
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.014
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.014
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.013
|
|
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.013
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.013
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.013
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.013
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.013
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.013
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.013
|
|
|
|
progesterone biosynthetic process
|
GO:0006701 |
1 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.013
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.013
|
|
|
|
regulation of inflammatory response to antigenic stimulus
|
GO:0002861 |
21 |
0.013
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.013
|
|
|
|
water soluble vitamin metabolic process
|
GO:0006767 |
10 |
0.013
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.013
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.012
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.012
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.012
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.012
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.012
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.012
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.012
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.012
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.012
|
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.012
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.012
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.012
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.012
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.012
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.012
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.012
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.012
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.012
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.012
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.012
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.012
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.012
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.012
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.012
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.012
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.012
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.012
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.012
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.012
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.012
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.012
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.012
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.012
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.012
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.011
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.011
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.011
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.011
|
|
|
|
regulation of calcidiol 1 monooxygenase activity
|
GO:0060558 |
1 |
0.011
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.011
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.011
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.011
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.011
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.011
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.011
|
Human |
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.011
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.011
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.011
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.011
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.011
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.011
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.011
|
Human Mouse |
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.011
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.011
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.011
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.011
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.011
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.011
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.011
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.011
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.011
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.011
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.011
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.011
|
Rat |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.011
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.010
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.010
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.010
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.010
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.010
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.010
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.010
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.010
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.010
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.010
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.010
|
Human |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.010
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.010
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.010
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.010
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.010
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.010
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.010
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.010
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.010
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.010
|
|